Raia Drogasil S.A.
RADLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $11,264,916 | $10,831,043 | $10,051,010 | $10,087,619 |
| % Growth | 4% | 7.8% | -0.4% | – |
| Cost of Goods Sold | $8,457,527 | $7,630,157 | $7,167,745 | $7,100,079 |
| Gross Profit | $2,807,389 | $3,200,886 | $2,883,265 | $2,987,540 |
| % Margin | 24.9% | 29.6% | 28.7% | 29.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $373,416 | $378,137 | $432,491 |
| SG&A Expenses | $2,073,884 | $2,481,501 | $2,408,701 | $2,462,463 |
| Sales & Mktg Exp. | $0 | $2,108,085 | $2,030,564 | $2,029,972 |
| Other Operating Expenses | -$12,830 | $2,841 | -$10,895 | -$5,454 |
| Operating Expenses | $2,061,054 | $2,484,342 | $2,397,806 | $2,457,009 |
| Operating Income | $746,335 | $716,544 | $485,459 | $530,531 |
| % Margin | 6.6% | 6.6% | 4.8% | 5.3% |
| Other Income/Exp. Net | -$201,779 | -$316,619 | -$285,060 | -$251,652 |
| Pre-Tax Income | $544,556 | $399,925 | $200,399 | $278,879 |
| Tax Expense | $82,875 | $16,980 | $35,320 | -$69,232 |
| Net Income | $453,972 | $374,004 | $163,967 | $348,232 |
| % Margin | 4% | 3.5% | 1.6% | 3.5% |
| EPS | 0.27 | 0.23 | 0.1 | 0.21 |
| % Growth | 17.4% | 130.9% | -52.6% | – |
| EPS Diluted | 0.27 | 0.23 | 0.099 | 0.21 |
| Weighted Avg Shares Out | 1,713,004 | 1,646,797 | 1,646,284 | 1,649,029 |
| Weighted Avg Shares Out Dil | 1,713,004 | 1,655,544 | 1,654,301 | 1,661,328 |
| Supplemental Information | – | – | – | – |
| Interest Income | $12,869 | $0 | $0 | $4 |
| Interest Expense | $273,304 | $278,711 | $217,296 | $214,225 |
| Depreciation & Amortization | $508,417 | $504,296 | $497,164 | -$474,809 |
| EBITDA | $1,325,250 | $1,182,932 | $914,859 | $11,388 |
| % Margin | 11.8% | 10.9% | 9.1% | 0.1% |